Last $0.07 USD
Change Today -0.101 / -57.71%
Volume 1.6M
VNTH On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

vantage health (VNTH) Key Developments

Vantage Health Deleted From OTCBB

Vantage Health’s common stock has been deleted from OTC Bulletin Board effective July 9, 2014 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.

Vantage Health Inc. announced delayed 10-Q filing

On 02/14/2014, Vantage Health Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Vantage Health and Scripps Translational Science Institute Form Strategic Partnership for Mobile Health Technology

Vantage Health Inc. and its parent company Nanobeak Inc. announced that they have formed a strategic partnership with Scripps Translational Science Institute (STSI) for the advancement of mobile health technology. Vantage Health is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a small device attached to a smartphone. STSI's Center for Digital Medicine is committed to helping in the development and research of novel mobile health devices to accelerate their uptake into clinical practice. Through this strategic partnership, STSI will assist in the testing, evaluation and detection of certain basic Volatile Organic Compounds (VOCs) using Gas Chromatography and Mass Spectrometry to calibrate the results of the Vantage sensor through validation. STSI will also assist in the testing, evaluation and detection of certain VOC's commonly associated with Lung Cancer, using Gas Chromatography and Mass Spectrometry to calibrate the results of the Vantage sensor through validation. STSI and Vantage Health will collaborate in the planning and execution of clinical trials. The actual clinical trials are expected to be carried out at STSI, as well as a 2nd location in the Midwest and a 3rd location in New England.

Vantage Health Inc Appoints William S. Rees, Jr. as Independent Member of the Board of Directors

Vantage Health Inc. announced the appointment of Dr. William S. Rees, Jr., as the first independent member of the Board of Directors of Vantage Health, Inc. Dr. William S. Rees, Jr. served 2006 - 2009 as the Deputy Under Secretary of Defense for Laboratories and Basic Sciences, and presently is the Managing Director of efkairia, LLC.

Vantage Health, Inc. Announces Board Changes

Vantage Health, Inc. announced that effective November 7, 2013, all members of board of directors, with the exception of Lisa Ramakrishnan, resigned from all positions as a director or officer of the company. At such time, Ms. Ramakrishnan resigned from all positions as an officer of the company only, but remains as a director. Effective November 7, 2013, Mr. Barbera was appointed as a director of the company, such that the board of directors of the company consists of Mr. Barbera and Ms. Ramakrishnan. Mr. Barbera was also appointed to the offices of Chief Executive Officer, Chief Financial Officer, President and Treasurer of the company at such time. Effective January 1, 2014, Ms. Ramakrishnan will resign as a director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNTH:US $0.07 USD -0.101

VNTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VNTH.
View Industry Companies
 

Industry Analysis

VNTH

Industry Average

Valuation VNTH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 178.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,087,366.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANTAGE HEALTH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.